Metabolic diseases such as obesity, fatty liver, and insulin resistance are rapidly increasing worldwide, but fundamental ...

Thepatent relates to potency assay methods for assessing human mesenchymal stem cells (MSCs) derived from bone marrow, adipose tissue, peripheral ...

The novel metabolic predictor emphasizes central adiposity, while integrating metabolites and other measures of metabolic ...

Our science-backed guide to beating belly fat, can help you trim down while also reducing the risk of heart disease and type ...

A multicenter research effort in China conducted clinical trial testing of oral berberine for six months in diabetes-free ...

Researchers have identified an enzyme that controls the maturation and long-term survival of tissue-resident macrophages.

Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are ...

Using data culled from nearly 11 million people, the researchers found that just over 19% were obese in 1990, compared to ...

In patients with obesity and MASLD but not diabetes, berberine is safe but does not reduce visceral adipose tissue or liver fat.

The rising incidence of cancer worldwide has led to an increasing number of surgeries that involve the removal of lymph nodes ...

Checking on seniors during this week’s extreme cold is important.

The George Institute for Global Health is thrilled to congratulate doctoral researcher Shaun Khanna on receiving a ...